Krebs Biochemicals & Industries Share Price & Stock Analysis

Krebs Biochemicals & Industries (BSE: 524518) is a Visakhapatnam, Andhra Pradesh-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹127 Cr, it ranks #3,039 by market cap among the 6,197 Indian listed companies on FinBizNet, and #65 of 86 in Medicinal Chemicals and Botanical Products. At ₹59.30 (as of 16 Nov 2026), the share price is 22.8% below its 52-week high of ₹76.85 and 54.7% above its 52-week low of ₹38.33. The share price is down 13.1% over one year and up 5.9% over three months.

Key Metrics

Current Price₹59.30
Market Cap₹127 Cr
BSE Code524518
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E RatioNot meaningful (loss)
Return on Equity10.96%
Return on Assets-3.75%
52-Week Range₹38.33 – ₹76.85
1-Year Price Change-13.1%
3-Month Price Change+5.9%
Beta (1Y)0.88
Dividend Yield0.00%
HeadquartersVisakhapatnam, Andhra Pradesh
Websitekrebsbiochem.com

Latest Quarterly Results — Q2 FY27

Revenue₹6 Cr
Net Profit₹-5 Cr
Net Margin-93.3%
EPS (Basic)₹-2.50
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Krebs Biochemicals & Industries Quarterly Revenue and Profit Trend

Krebs Biochemicals & Industries reported revenue of ₹6 Cr in Q2 FY27, up 38.8% from ₹4 Cr in Q2 FY26 and down 17.0% from ₹7 Cr in Q1 FY27. It posted a net loss of ₹5 Cr for the quarter, against a net loss of ₹6 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹4 Cr (Q2 FY26) to ₹7 Cr (Q3 FY26). The company reported a net loss in 7 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹6 Cr−₹5 Cr−93.3%
Q1 FY27₹7 Cr−₹2 Cr−35.5%
Q4 FY26₹7 Cr−₹2 Cr−34.4%
Q3 FY26₹7 Cr−₹3 Cr−43.1%
Q2 FY26₹4 Cr−₹6 Cr−147.2%
Q1 FY26₹5 Cr−₹5 Cr−97.1%
Q4 FY25₹6 Cr−₹8 Cr−135.6%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 72.74% of Krebs Biochemicals & Industries's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 64.4% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Krebs Biochemicals & Industries

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Products and Services

1. Segment Adjustment-This segment manufactures active pharmaceutical ingredients. 2. Pharma-This segment produces potato crisps. It also engages in the manufacture and sale of sugar. 3. Food-This segment manufactures sugar. 4. Sugar-0

Business Segments

1. Pharma-100%

Krebs Biochemicals & Industries vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Krebs Biochemicals & Industries₹127 Crn/m10.96%₹6 Cr-13.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Krebs Biochemicals & Industries?

Krebs Biochemicals & Industries is trading at ₹59.30, with a market capitalisation of ₹127 Cr.

Which sector does Krebs Biochemicals & Industries belong to?

Krebs Biochemicals & Industries operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Krebs Biochemicals & Industries?

Krebs Biochemicals & Industries has a return on equity of 10.96%.

What is the stock symbol of Krebs Biochemicals & Industries?

Krebs Biochemicals & Industries is listed on the BSE under the scrip code 524518.

How has Krebs Biochemicals & Industries's share price moved over the past year?

Krebs Biochemicals & Industries's share price is down 13.1% over one year and up 5.9% over three months. Its 52-week range is ₹38.33 to ₹76.85.

What were Krebs Biochemicals & Industries's latest quarterly results?

In Q2 FY27, Krebs Biochemicals & Industries reported revenue of ₹6 Cr and net profit of ₹-5 Cr, with basic EPS of ₹-2.5 (standalone, parsed from the company's exchange filing).

How have Krebs Biochemicals & Industries's revenue and profit changed over the past year?

Krebs Biochemicals & Industries reported revenue of ₹6 Cr in Q2 FY27, up 38.8% from ₹4 Cr in Q2 FY26 and down 17.0% from ₹7 Cr in Q1 FY27.

What is the promoter holding in Krebs Biochemicals & Industries?

Promoters held 72.74% of Krebs Biochemicals & Industries's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.